Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C

Journal of Hepatology

Volumn 36, Issue 6, 2002, Pages 812-818

  Cacoub, Patrice ^a   Ratziu, Vlad ^a   Myers, Robert P ^a   Ghillani, Pascale ^a   Piette, Jean Charles ^a   Moussalli, Joseph ^a   Poynard, Thierry ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Arthralgia; Cryoglobulin; Extrahepatic manifestation; Fatigue; Hepatitis C virus; Myalgia

Indexed keywords

ANTIVIRUS AGENT; VIRUS RNA;

ADULT; AGE DISTRIBUTION; ARTHRALGIA; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FATIGUE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MYALGIA; PARESTHESIA; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SJOEGREN SYNDROME; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; ARTHRALGIA; COHORT STUDIES; CRYOGLOBULINEMIA; DEPRESSION; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRES;

EID: 0036623222     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00067-3     Document Type: Article

References (45)

1. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992;117(7):573-577.
2. Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999;42(10): 2204-2212.
3. Ferri C, Greco F, Longombardo G, Palla P, Marzo E, Moretti A. Hepatitis C virus antibodies in mixed cryoglobulinemia. Clin Exp Rheumatol 1991;9(1):95-96.
4. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995;123(8):615-620.
5. Cacoub P, Musset L, Amoura Z, Guilani P, Chabre H, Lunel F, et al. Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group. J Rheumatol 1997;24(11):2139-2144.
6. Abuaf N, Lunel F, Giral P, Borotto E, Laperche S, Poupon R, et al. Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 1993;18(3):359-364.
7. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995;21(3):613-619.
8. Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999;29(1):264-270.
9. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998;27(1):209-212.
10. Foster GR. Hepatitis C virus infection: quality of life and side effects of treatment. J Hepatol 1999;31(Suppl 1):250-254.
11. Ware Jr JE, Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology 1999;30(2):550-555.
12. Lunel F, Cacoub P. Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection. J Hepatol 1999;31(Suppl 1):210-216.
13. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, et al. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994;330(11):751-756.
14. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825-832.
15. Musset L, Diemert MC, Taibi F, Thi Huong Du L, Cacoub P, Leger JM, et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992;38(6):798-802.
16. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974;57(5):775-788.
17. Abel G, Zhang QX, Agnello V. Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 1993;36(10):1341-1349.
18. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69(2):287-308.
19. Cable E. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994;20(1 Pt 1):15-20.
20. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24(2):289-293.
21. McHutchison JG, Ware Jr JE, Bayliss MS, Pianko S, Albrecht JK, Cort S, et al. Hepatitis Interventional Therapy Group. The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol 2001;34:140-147.
22. Kleinman L, Zodet MW, Hakim Z, Aledort J, Barker C, Chan K, et al. Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Qual Life Res 2000;9(5):499-508.
23. Dhumeaux D, Doffoel M, Galmiche JP. A French consensus conference on hepatitis C: screening and treatment. J Hepatol 1997;27(5): 941-944.
24. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 1998;352(9138):1426-1432.
25. Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ. Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res 2000;49(5):311-317.
26. Goulding C, O'Connell P, Murray FE. Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition. Eur J Gastroenterol Hepatol 2001;13(5):507-511.
27. Obhrai J, Hall Y, Anand BS. Assessment of fatigue and psychologic disturbances in patients with hepatitis C virus infection. J Clin Gastroenterol 2001;32(5):413-417.
28. Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999;30(5):1299-1301.
29. Jones EA. Altered central serotoninergic neurotransmission: a potential mechanism for profound fatigue complicating chronic hepatitis C. Med Hypotheses 2001;57(2):133-134.
30. Gershon AS, Margulies M, Gorczynski RM, Heathcote EJ. Serum cytokine values and fatigue in chronic hepatitis C infection. J Viral Hepat 2000;7(6):397-402.
31. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001;358:38-39.
32. Wessely S. Chronic fatigue: symptom and syndrome. Ann Intern Med 2001;134(9 Pt 2):838-843.
33. Pawlikowska T, Chalder T, Hirsch SR, Wallace P, Wright DJ, Wessely SC. Population based study of fatigue and psychological distress. Br Med J 1994;308:763-766.
34. Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, et al. A community-based study of chronic fatigue syndrome. Arch Intern Med 1999;159(18):2129-2137.
35. McDonald E, David AS, Pelosi AJ, Mann AH. Chronic fatigue in primary care attenders. Psychol Med 1993;23(4):987-998.
36. Apartis E, Léger JM, Musset L, Gugenheim M, Cacoub P, Lyon Caen O, et al. Peripheral neuropathy associated with essential mixed cryoglobulinemia: a role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry 1996;60:661-666.
37. Zuckerman E, Keren D, Slobodin G, Rosner I, Rozenbaum M, Toubi E, et al. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 2000;27(9):2172-2178.
38. Boadas J, Rodriguez-Espinosa J, Enriquez J, Miralles F, Martinez-Cerezo FJ, Gonzalez P, et al. Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J Hepatol 1995;22(6):611-615.
39. Huang MJ, Tsai SL, Huang BY, Sheen IS, Yeh CT, Liaw YF. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study. Clin Endocrinol (Oxf) 1999;50(4):503-509.
40. Goh J, Coughlan B, Quinn J, O'Keane JC, Crowe J. Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur J Gastroenterol Hepatol 1999;11(8):833-838.
41. Remy AJ, Daures JP, Tanguy G, Khemissa F, Chevrier M, Lezotre PL, et al. Measurement of the quality of life in chronic hepatitis C: validation of a general index and specific index. First French results (in French). Gastroenterol Clin Biol 1999;23(12):1296- 1309.
42. Levo Y, Gorevic PD, Kassab H, Zucker-Franklin D, Gigli I, Franklin EC. Mixed cryoglobulinemia-an immune complex disease often associated with hepatitis B virus infection. Trans Assoc Am Physicians 1977;90:167-173.
43. Hamburger MI, Gorevic PD, Lawley TJ, Franklin EC, Frank MM. Mixed cryoglobulinemia: association of glomerulonephritis with defective reticuloendothelial system Fc receptor function. Trans Assoc Am Physicians 1979;92:104-112.
44. Friedman SL. Cellular networks in hepatic fibrosis. Digestion 1998;59(4):368-371.
45. Sobesky R, Mathurin P, Charlotte F, Moussalli J, Olivi M, Vidaud M, et al. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group. Gastroenterology 1999;116(2):378-386.